Insilico Medicine Raises $123 Million with Oversubscribed Series E Funding Round
Cambridge, MA — In an impressive demonstration of investor confidence and technological promise, Insilico Medicine, a trailblazing clinical-stage biotech company ...
Cambridge, MA — In an impressive demonstration of investor confidence and technological promise, Insilico Medicine, a trailblazing clinical-stage biotech company ...
Insilico Medicine, a pioneering entity in the realm of drug discovery, recently garnered significant attention following its successful completion of ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine